| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 22,985 | 19,262 | 14,565 | 18,861 | | Cost of Revenue | 2,731 | 5,020 | 5,451 | 1,396 | | | Gross Profit | 20,254 | 14,242 | 9,114 | 17,465 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| (2,331) | | Selling General and Administrative | 5,208 | 2,397 | 2,990 | 12,823 | | Non Recurring | 988 | 128 |
-
| 8,339 | | Others | 6,310 | 4,725 | 4,468 | 4,724 | | | | Total Operating Expenses |
-
|
-
|
-
| 23,555 | | | | Operating Income or Loss | 7,748 | 6,992 | 1,656 | (6,090) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,516 | (133) |
-
| (440) | | Earnings Before Interest And Taxes | 7,554 | 6,859 | 1,656 | (6,530) | | Interest Expense | 1,586 | 1,144 | 819 | 962 | | Income Before Tax | 5,968 | 5,715 | 837 | (7,492) | | Income Tax Expense | 2,540 | 2,216 | 360 | (3,201) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 7,262 | 3,499 | 477 | (4,291) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,428 | 3,499 | 477 | (4,291) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,428 | $3,499 | $477 | ($4,291) |
|
0.31% Nasdaq 0.00%
Income Statement
